Source: International Journal of Retina and Vitreous. Unidade: FMRP
Subjects: RETINA, DIABETES MELLITUS, HEMORRAGIA, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
ABNT
JORGE, Danilo Moyses et al. Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial. International Journal of Retina and Vitreous, v. 7, n. 1, p. 1-9, 2021Tradução . . Disponível em: https://doi.org/10.1186/s40942-021-00296-7. Acesso em: 17 out. 2024.APA
Jorge, D. M., Tavares Neto, J. E. da S., Poli Netto, O. B., Scott, I. U., & Jorge, R. (2021). Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial. International Journal of Retina and Vitreous, 7( 1), 1-9. doi:10.1186/s40942-021-00296-7NLM
Jorge DM, Tavares Neto JE da S, Poli Netto OB, Scott IU, Jorge R. Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial [Internet]. International Journal of Retina and Vitreous. 2021 ; 7( 1): 1-9.[citado 2024 out. 17 ] Available from: https://doi.org/10.1186/s40942-021-00296-7Vancouver
Jorge DM, Tavares Neto JE da S, Poli Netto OB, Scott IU, Jorge R. Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial [Internet]. International Journal of Retina and Vitreous. 2021 ; 7( 1): 1-9.[citado 2024 out. 17 ] Available from: https://doi.org/10.1186/s40942-021-00296-7